Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Vet Pathol ; 41(5): 498-505, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15347822

ABSTRACT

A Chlamydophila abortus-induced abortion model was carried out on the basis of the experimental infection of ewes at day 75 of gestation. The infection induced abortions and the birth of weak lambs during the last 3 weeks of pregnancy. To study the kinetics of the infection in the placenta and in other organs, infected ewes were killed at 105, 120, and 130 days of gestation and also several days after abortion or parturition. Infected ewes developed a systemic infection that caused a mild and transient pneumonia and focal hepatitis. Pathologic changes were observed in placentas at 120 day of gestation, although the lesions varied between animals and even between placentomes of the same placenta. The first placental area infected was the maternal stroma and epithelium next to the intercaruncular areas, where neutrophilic response seemed to control the infection. A substantial degree of multiplication of C. abortus was then observed in the trophoblast cells of the placentome, periplacentomal choriallantoic membranes, and hilius, with an inflammatory exudate composed mainly of neutrophils, some macrophages, and very scarce lymphocytes. After abortion, the lesions affected the intercotyledonary areas of the aborted placentas, whereas in the uterus significant lymphocyte infiltration was observed, together with a rapid decrease of the C. abortus antigen in the degenerated caruncular tissues.


Subject(s)
Abortion, Veterinary/microbiology , Chlamydophila Infections/veterinary , Chlamydophila/isolation & purification , Placenta Diseases/veterinary , Pregnancy, Animal , Sheep Diseases/microbiology , Sheep Diseases/pathology , Animals , Chlamydophila Infections/microbiology , Chlamydophila Infections/pathology , Enzyme-Linked Immunosorbent Assay/veterinary , Female , Immunohistochemistry/veterinary , Lung/pathology , Placenta Diseases/microbiology , Placenta Diseases/pathology , Pregnancy , Sheep
2.
Vet Microbiol ; 100(1-2): 65-76, 2004 May 20.
Article in English | MEDLINE | ID: mdl-15135514

ABSTRACT

The protective efficacy of two inactivated commercial (A, B) and two new inactivated vaccines (M7, QS) against ovine enzootic abortion was determined in two separate experiments in sheep. Vaccine A contained chlamydiae propagated in chicken embryos, adjuvated with Marcol 82, and vaccine B contained chlamydiae cultured in cell monolayers, adjuvated with aluminium hydroxide. For the preparation of the experimental vaccines, Chlamydophila abortus AB7 strain was cultured in McCoy cells and adjuvated with QS-21 (QS) or Montanide ISA 773 (M7). The ewes were vaccinated twice subcutaneously and challenged at 90 days of gestation. Protection was evaluated by clinical, bacteriological and serological examinations, and compared to two control groups: one of infected but not vaccinated ewes, and another of vaccinated but not infected ewes. The experimental vaccines induced considerably better protection than the two commercial ones. The new vaccine M7 especially showed no abortions, a good antibody response, the highest newborn lamb weights and the lowest level of C. abortus shedding at lambing.


Subject(s)
Abortion, Veterinary/prevention & control , Bacterial Vaccines/therapeutic use , Chlamydophila Infections/veterinary , Chlamydophila/immunology , Sheep Diseases/microbiology , Sheep Diseases/prevention & control , Vaccination/veterinary , Abortion, Veterinary/immunology , Abortion, Veterinary/microbiology , Animals , Animals, Newborn , Antibodies, Bacterial/blood , Bacterial Vaccines/immunology , Body Temperature , Body Weight , Chlamydophila Infections/immunology , Chlamydophila Infections/microbiology , Chlamydophila Infections/prevention & control , Enzyme-Linked Immunosorbent Assay , Female , Male , Pregnancy , Random Allocation , Sheep , Sheep Diseases/immunology , Vaccines, Inactivated/immunology , Vaccines, Inactivated/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...